At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 120 enrolled
Drug / intervention
Sitagliptin +1 moredrug
Likely dose
pioglitazone 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Adding Sitagliptin or Pioglitazone to Patients With Type 2 Diabetes Insufficiently Controlled With Metformin and Sulfonylurea
In Brief
A Phase 4 clinical trial evaluating Sitagliptin and pioglitazone for Type 2 Diabetes. Completed, enrolled 120 participants across 1 site.
Detailed Summary
This 24-weeks study will to compare the glycemic efficacy and safety of sitagliptin with pioglitazone in patients with type 2 diabetes who had inadequate glycemic control despite dual therapy with metformin and a sulfonylurea.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesTaiwan
CollaboratorsMackay Memorial Hospital
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedSep 2010
Primary CompletionOct 2011
Study CompletionApr 2012
TodayJul 2026
First PostedSep 3, 2010
Enrollment StartOct 1, 2009
Primary CompletionOct 1, 2011
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.8 years ago
Interventions
Sitagliptindrug
add sitagliptin100mg/d to pre-study OADs
pioglitazonedrug
add pioglitazone 30mg/d to pre-study OADs